Related Experiment Video
Updated: May 3, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Gene Expression Profiling Identifies Important Genes Affected by R2 Compound Disrupting FAK and P53 Complex
Vita M Golubovskaya1, Baotran Ho2, Jeffrey Conroy3
1Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. Vita.Golubovskaya@roswellpark.org.
Roslin 2 (R2) compound disrupts Focal Adhesion Kinase (FAK) and p53, activating p53 and blocking tumor growth. Combining R2 with other drugs targeting FAK, Mdm-2, and p53 shows promise for colon cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Focal Adhesion Kinase (FAK) is crucial for cellular processes including proliferation, invasion, and metastasis.
- The compound Roslin 2 (R2) has demonstrated the ability to disrupt FAK and p53 interactions, activate p53, and inhibit tumor growth.
Purpose of the Study:
- To investigate the gene expression profile of R2-treated colon cancer cells.
- To evaluate the therapeutic potential of combining R2 with other agents targeting FAK, Mdm-2, and p53.
Main Methods:
- Microarray gene expression analysis was performed on R2-treated HCT116 p53+/+ and p53-/- cells.
- Gene expression changes were analyzed to identify R2-responsive genes in a p53-dependent manner.
- Combinatorial drug treatments were assessed for their effect on colon cancer cell clonogenicity.
Main Results:
- R2 treatment significantly altered the expression of 1484 genes in HCT116 p53+/+ cells, including key p53 targets like Mdm-2, Noxa-1, and RIP1.
- Down-regulated genes included Met, PLK2, KIF14, and BIRC2.
- Combined treatment with R2 and M13 or Nutlin-1 compounds synergistically reduced colon cancer cell clonogenicity in a p53-dependent manner.
Conclusions:
- R2 treatment induces a distinct gene expression profile in colon cancer cells, mediated by p53.
- Combination therapies targeting FAK, Mdm-2, and p53 represent a promising novel therapeutic strategy for colon cancer.
Related Concept Videos
Abnormal Proliferation
Reporter Genes
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
What is Gene Expression?

